2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Symposium

[SY18] Symposium 18　PARP inhibitor for Ovarian Cancer Treatment
【SI】【E】

Fri. Feb 18, 2022 3:05 PM - 4:35 PM Room 7 (Room E, 1F, Kyoto International Conference Center)

Chair：Keiichi Fujiwara（Department of Gynecologic Oncology, Saitama Medical University），Mansoor Raza Mirza（Department of Oncology, The Nordic Society of Gynecological Oncology and Rigshospitalet-Copenhagen University Hospital）

[SY18-4] The reason why platinum sensitivity is used for a clinical biomarker of PARP inhibitor sensitivity may be explained by the Schlafen 11 (SLFN11)

○Murai Junko (Institute for Advanced Biosciences, Keio University)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password